Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors. The company was founded by CEO Leonard Schleifer and scientist George Yancopoulos in 1988. Regeneron has developed aflibercept, a VEGF inhibitor, and rilonacept, an interleukin-1 blocker. VEGF is a protein that normally stimulates the growth of blood vessels, and interleukin-1 is a protein that is normally involved in inflammation. More information...
According to PR-model, regeneron.com is ranked 127,546th in multilingual Wikipedia, in particular this website is ranked 89,683rd in English Wikipedia.
The website is placed before the-berkeley.co.uk and after lesagentsassocies.com in the BestRef global ranking of the most important sources of Wikipedia.